期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 51, 期 11, 页码 4202-4204出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00181-07
关键词
-
The diarylquinoline R207910 is in clinical development for tuberculosis treatment. The MIC50 for 41 drug-susceptible and 44 multidrug-resistant Mycobacterium tuberculosis clinical isolates was 0.032 mu g/ml. Out of 20 additional mycobacterial species, three were found to be naturally resistant to R207910 and were shown to exhibit a polymorphism in their atpE genes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据